miR-199a Knockdown Alleviates Insulin Resistance and Inflammation by Targeting DDIT4 via the PI3K/AKT Pathway in vitro and in vivo.

Saved in:
Bibliographic Details
Title: miR-199a Knockdown Alleviates Insulin Resistance and Inflammation by Targeting DDIT4 via the PI3K/AKT Pathway in vitro and in vivo.
Authors: Cai YW; Department of Geriatrics, Ningbo No.2 Hospital, Ningbo, Zheijiang, 315000, People's Republic of China., Tang LJ; Department of Geriatrics, Ningbo No.2 Hospital, Ningbo, Zheijiang, 315000, People's Republic of China., Zhu Y; Department of Geriatrics, Ningbo No.2 Hospital, Ningbo, Zheijiang, 315000, People's Republic of China., Ye SS; Department of Geriatrics, Ningbo No.2 Hospital, Ningbo, Zheijiang, 315000, People's Republic of China., Chen TE; Department of General Medicine, Ningbo No.2 Hospital, Ningbo, Zheijiang, 315000, People's Republic of China.
Source: Diabetes, metabolic syndrome and obesity : targets and therapy [Diabetes Metab Syndr Obes] 2025 Dec 31; Vol. 18, pp. 4931-4942. Date of Electronic Publication: 2025 Dec 31 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101515585 Publication Model: eCollection Cited Medium: Print ISSN: 1178-7007 (Print) Linking ISSN: 11787007 NLM ISO Abbreviation: Diabetes Metab Syndr Obes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first